Be the first to review. Register
|
|||||||||||||||
|
|||||||||||||||
Abstract
Natural products have taught researchers about the properties that
make molecules adept at getting into cells and binding proteins
and the many ways they can fail. However, it moves at a
relatively slow pace, entailing the collection and preparation of
specimens and the isolation, purification, and structural
determination of active agents. Inadvertently these make natural
products research appear tedious and expensive. The rapid assays
used by pharmaceutical companies demand a steady flow of new
compounds to screen. All these factors have led many
pharmaceutical companies to cut off natural products programs.
Chapter
| Chapter 1 : Jack Cannon Plenary Lecture |
| Chapter 2 : Invited Paper |
| Chapter 3 : Biological and Phytochemical Screening |
| Chapter 4 : Chemical Fingerprinting/Structure Elucidation |
| Chapter 5 : Essential & other Volatile Oils |
| Chapter 6 : Biotransformation/Chemical Transformation |
| Chapter 7 : Genetic Engineering |
